Company intelligence / Profile preview

Scope Pharma

Australia

Ownership: Private
Development stage: Other

Overview

Scope Pharma supplies TGA-compliant prescription, OTC, and specialty medicines to Australia, New Zealand, and Asia-Pacific, connecting global manufacturers with local health systems. No clinical results, as company doesn't develop own products.

Modalities: Small moleculeBiologic
Industry: Non-Academic Healthcare

Partnerships

Partners with global/local pharmaceutical manufacturers for sourcing and supply

Beyond the preview

Go deeper on Scope Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scope Pharma.

Explore the full profile